Gelteq LtdNASDAQ:GELS
- LAST PRICE1.8300
- TODAY'S CHANGE (%)0.2600 (16.5605%)
- Bid / Lots1.7600/ 6
- Ask / Lots1.9900/ 2
- Open / Previous Close1.7200 / 1.5700
- Day Range
- 52 Week Range
- Volume33,297
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | GELS |
|---|---|---|
| 09:32 ET | 406 | 1.72 |
| 09:51 ET | 100 | 1.71 |
| 09:53 ET | 2000 | 1.7 |
| 10:09 ET | 155 | 1.7 |
| 10:18 ET | 100 | 1.5 |
| 10:27 ET | 100 | 1.59 |
| 10:29 ET | 100 | 1.6 |
| 10:54 ET | 5900 | 1.6766 |
| 02:23 ET | 399 | 1.7 |
| 02:34 ET | 2200 | 1.76 |
| 02:36 ET | 4448 | 1.79 |
| 03:08 ET | 978 | 1.8 |
| 03:12 ET | 700 | 1.98 |
| 03:14 ET | 600 | 1.98 |
| 03:15 ET | 3090 | 1.85 |
| 03:19 ET | 3000 | 1.85 |
| 03:21 ET | 2987 | 1.83 |
Nov 12, 2024
Gelteq Expands Operations in United States with Appointment of Adam Bendell as President of U.S. Operations to Scale Domestic Business, from 9:00AM ET on Tuesday Nov 12, 2024 by Dow Jones
9:00AM ET on Tuesday Nov 12, 2024 by Dow JonesPress Release: Gelteq Expands Operations in United States with Appointment of Adam Bendell as President of U.S. Operations to Scale Domestic Business, from 9:00AM ET on Tuesday Nov 12, 2024 by Dow Jones
9:00AM ET on Tuesday Nov 12, 2024 by Dow Jones
Oct 30, 2024
Gelteq Limited Closes US$5.2 Million Initial Public Offering, from 10:00AM ET on Wednesday Oct 30, 2024 by Dow Jones
10:00AM ET on Wednesday Oct 30, 2024 by Dow Jones*DJ Gelteq Limited Closes US$5.2 M Initial Public Offering, from 10:00AM ET on Wednesday Oct 30, 2024 by Dow Jones
10:00AM ET on Wednesday Oct 30, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Gelteq Ltd | 14.8M | -11.4x | --- |
NDT Pharmaceuticals Inc | 9.5M | --- | --- |
Eyenovia Inc | 9.1M | -0.1x | --- |
Coeptis Therapeutics Holdings Inc | 7.8M | -0.6x | --- |
Transnational Cannabis Ltd | 10.7M | 0.0x | --- |
GT Biopharma Inc | 6.7M | -0.4x | --- |
Company Information
Gelteq Limited is an Australia-based clinical and science-based company. The Company is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. The Company offers a complete end-to-end service for the development of new products and the conversion of existing products and formulations into gels. Its product suite consists of multiple products that sit within five core verticals - for pets, sports, pharmaceuticals (pharma), over-the-counter (OTC) and nutraceuticals. The Company’s delivery system provides pharma and nutraceutical enhancements throughout every stage of ingestion in both animals and humans, addressing the complete experience from the point of ingestion to final absorption. The Company also offers a highly versatile portfolio of pre-tested and market-ready proprietary formulations that can be white-labelled.
Contact Information
- Headquarters
- Level 4, 100 Albert RoadMELBOURNE, VIC, Australia 3205
- Phone
- ---
- Fax
- ---
Executives
- Executive Chairman of the Board
- Simon Szewach
- Chief Executive Officer, Executive Director
- Nathan Givoni
- Chief Financial Officer
- Anthony Panther
- Independent Non-Executive Director
- Philip Dalidakis
- Independent Non-Executive Director
- David Morton
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $14.8M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 9.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.16 |
Book Value | $1.62 |
P/E Ratio | -11.4x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
